• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
73,832.55 -150.63
( -0.20%)
Global Indices
Nasdaq
49,934.70 -958.41
(-1.88%)
Dow Jones
7,287.94 -119.71
(-1.62%)
Hang Seng
64,050.08 -129.19
(-0.20%)
Nikkei 225
10,254.58 27.25
(0.27%)
Forex
USD-INR
95.41 -0.12
(-0.12%)
EUR-INR
110.18 0.04
(0.03%)
GBP-INR
127.60 0.17
(0.13%)
JPY-INR
0.60 0.00
(-0.17%)

EQUITY - MARKET SCREENER

Onyx Biotec Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
93585
INE0WVU01018
30.5601085
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ONYX
0
72.53
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

TCI Finance standalone net profit declines 97.57% in the March 2026 quarter
May 26,2026
Net profit of TCI Finance declined 97.57% to Rs 0.11 crore in the quarter ended March 2026 as against Rs 4.53 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 and during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 1.78 crore in the year ended March 2026 as against net profit of Rs 3.58 crore during the previous year ended March 2025. There were no Sales reported in the year ended March 2026 and during the previous year ended March 2025.